{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:54:55Z","timestamp":1777114495808,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"DOI":"10.7759\/cureus.98268","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T23:22:37Z","timestamp":1764631357000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Delirium Caused by Short-Term Administration of Compound Paracetamol and Amantadine Hydrochloride Capsules in an Elderly Patient With Extremely Low Body Weight"],"prefix":"10.7759","author":[{"given":"Yu","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jufen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenfu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Amantadine","author":"Chang C","year":"2025","unstructured":"Chang C, Ramphul K. Amantadine. StatPearls Publishing, Treasure Island; 2025."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","author":"American Geriatrics Society","year":"2023","unstructured":"American Geriatrics Society. American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023, 71:2052-81. 10.1111\/jgs.18372","journal-title":"J Am Geriatr Soc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2024.2424422","article-title":"Pharmacology of chlorphenamine and pseudoephedrine use in the common cold: a narrative review","volume":"40","author":"Douhard R","year":"2024","unstructured":"Douhard R, Humbert P, Milon JY, Pegahi R. Pharmacology of chlorphenamine and pseudoephedrine use in the common cold: a narrative review. Curr Med Res Opin. 2024, 40:2125-37. 10.1080\/03007995.2024.2424422","journal-title":"Curr Med Res Opin"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13669","article-title":"Central nervous system adverse reactions to amantadine intoxication: a case report and analysis of JADER","volume":"38","author":"Ide N","year":"2024","unstructured":"Ide N, Hosoya Y, Yamamoto M, Shigeno A, Obayashi M, Asada K, Matsushima S. Central nervous system adverse reactions to amantadine intoxication: a case report and analysis of JADER. In Vivo. 2024, 38:2090-6. 10.21873\/invivo.13669","journal-title":"In Vivo"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2490\/prm.20170017","article-title":"Case reports describing amantadine intoxication in a rehabilitation hospital","volume":"2","author":"Kunieda K","year":"2017","unstructured":"Kunieda K, Shigematsu T, Fujishima I. Case reports describing amantadine intoxication in a rehabilitation hospital. Prog Rehabil Med. 2017, 2:20170017. 10.2490\/prm.20170017","journal-title":"Prog Rehabil Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2008.08.005","article-title":"Plasma amantadine concentrations in patients with Parkinson's disease","volume":"15","author":"Nishikawa N","year":"2009","unstructured":"Nishikawa N, Nagai M, Moritoyo T, Yabe H, Nomoto M. Plasma amantadine concentrations in patients with Parkinson's disease. Parkinsonism Relat Disord. 2009, 15:351-3. 10.1016\/j.parkreldis.2008.08.005","journal-title":"Parkinsonism Relat Disord"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2004.07.009","article-title":"Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale","volume":"29","author":"Gaudreau JD","year":"2005","unstructured":"Gaudreau JD, Gagnon P, Harel F, Tremblay A, Roy MA. Fast, systematic, and continuous delirium assessment in hospitalized patients: the nursing delirium screening scale. J Pain Symptom Manage. 2005, 29:368-75. 10.1016\/j.jpainsymman.2004.07.009","journal-title":"J Pain Symptom Manage"},{"key":"ref8","article-title":"Volume of Distribution","author":"Mansoor A","year":"2025","unstructured":"Mansoor A, Mahabadi N. Volume of Distribution. StatPearls Publishing, Treasure Island; 2025."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.25","article-title":"Amantadine kinetics in healthy elderly men: implications for influenza prevention","volume":"37","author":"Aoki FY","year":"1985","unstructured":"Aoki FY, Sitar DS. Amantadine kinetics in healthy elderly men: implications for influenza prevention. Clin Pharmacol Ther. 1985, 37:137-44. 10.1038\/clpt.1985.25","journal-title":"Clin Pharmacol Ther"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198814010-00003","article-title":"Clinical pharmacokinetics of amantadine hydrochloride","volume":"14","author":"Aoki FY","year":"1988","unstructured":"Aoki FY, Sitar DS. Clinical pharmacokinetics of amantadine hydrochloride. Clin Pharmacokinet. 1988, 14:35-51. 10.2165\/00003088-198814010-00003","journal-title":"Clin Pharmacokinet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1979266729","article-title":"Amantadine kinetics in healthy young subjects after long-term dosing","volume":"26","author":"Aoki FY","year":"1979","unstructured":"Aoki FY, Sitar DS, Ogilvie RI. Amantadine kinetics in healthy young subjects after long-term dosing. Clin Pharmacol Ther. 1979, 26:729-36. 10.1002\/cpt1979266729","journal-title":"Clin Pharmacol Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-94-4-454","article-title":"Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function","volume":"94","author":"Horadam VW","year":"1981","unstructured":"Horadam VW, Sharp JG, Smilack JD, et al.. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Ann Intern Med. 1981, 94:454-8. 10.7326\/0003-4819-94-4-454","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1605501","article-title":"Delirium in hospitalized older adults","volume":"377","author":"Marcantonio ER","year":"2017","unstructured":"Marcantonio ER. Delirium in hospitalized older adults. N Engl J Med. 2017, 377:1456-66. 10.1056\/NEJMcp1605501","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230227","article-title":"Antipsychotic medications for older adults with delirium admitted to hospital","volume":"195","author":"Reppas-Rindlisbacher C","year":"2023","unstructured":"Reppas-Rindlisbacher C, Wiesenfeld L, Stall NM. Antipsychotic medications for older adults with delirium admitted to hospital. CMAJ. 2023, 195:E1038-9. 10.1503\/cmaj.230227","journal-title":"CMAJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.25182013","article-title":"The American Psychiatric Association Practice Guideline for the prevention and treatment of delirium","volume":"182","author":"Crone C","year":"2025","unstructured":"Crone C, Fochtmann LJ, Ahmed I, et al.. The American Psychiatric Association Practice Guideline for the prevention and treatment of delirium. Am J Psychiatry. 2025, 182:880-4. 10.1176\/appi.ajp.25182013","journal-title":"Am J Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002745.pub4","article-title":"Amantadine and rimantadine for influenza A in children and the elderly","volume":"2014","author":"Alves Galv\u00e3o MG","year":"2014","unstructured":"Alves Galv\u00e3o MG, Rocha Crispino Santos MA, Alves da Cunha AJ. Amantadine and rimantadine for influenza A in children and the elderly. Cochrane Database Syst Rev. 2014, 2014:CD002745. 10.1002\/14651858.CD002745.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001169.pub3","article-title":"Amantadine and rimantadine for influenza A in adults","volume":"2006","author":"Jefferson T","year":"2006","unstructured":"Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Amantadine and rimantadine for influenza A in adults. Cochrane Database Syst Rev. 2006, 2006:CD001169. 10.1002\/14651858.CD001169.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-024-01169-y","article-title":"Influenza and aging: clinical manifestations, complications, and treatment approaches in older adults","volume":"42","author":"Rosero CI","year":"2025","unstructured":"Rosero CI, Gravenstein S, Saade EA. Influenza and aging: clinical manifestations, complications, and treatment approaches in older adults. Drugs Aging. 2025, 42:39-55. 10.1007\/s40266-024-01169-y","journal-title":"Drugs Aging"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19053018","article-title":"Antiviral drugs in influenza","volume":"19","author":"\u015awierczy\u0144ska M","year":"2022","unstructured":"\u015awierczy\u0144ska M, Mirowska-Guzel DM, Pindelska E. Antiviral drugs in influenza. Int J Environ Res Public Health. 2022, 19:3018. 10.3390\/ijerph19053018","journal-title":"Int J Environ Res Public Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2010.0543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt S","year":"2010","unstructured":"Holt S, Schmiedl S, Th\u00fcrmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010, 107:543-51. 10.3238\/arztebl.2010.0543","journal-title":"Dtsch Arztebl Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-022-03279-x","article-title":"Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis","volume":"22","author":"Delara M","year":"2022","unstructured":"Delara M, Murray L, Jafari B, et al.. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatr. 2022, 22:601. 10.1186\/s12877-022-03279-x","journal-title":"BMC Geriatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/436606-severe-delirium-caused-by-short-term-administration-of-compound-paracetamol-and-amantadine-hydrochloride-capsules-in-an-elderly-patient-with-extremely-low-body-weight","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T23:22:48Z","timestamp":1764631368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/436606-severe-delirium-caused-by-short-term-administration-of-compound-paracetamol-and-amantadine-hydrochloride-capsules-in-an-elderly-patient-with-extremely-low-body-weight"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.98268","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}